FEDERATED HERMES, INC. - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$7,000
-22.2%
1,809
+6.1%
0.00%–
Q4 2019$9,0000.0%1,705
-6.2%
0.00%–
Q3 2019$9,000
-99.9%
1,818
-99.9%
0.00%
-100.0%
Q4 2018$14,496,000
-64.0%
3,451,447
-46.2%
0.04%
-57.4%
Q3 2018$40,245,000
-28.5%
6,418,600
-8.3%
0.09%
-43.0%
Q2 2018$56,248,000
-26.0%
6,996,055
-31.3%
0.16%
-25.3%
Q1 2018$76,001,000
+25.4%
10,187,7630.0%0.22%
+29.2%
Q4 2017$60,617,000
-22.4%
10,187,763
-4.0%
0.17%
-23.7%
Q3 2017$78,145,000
+5.5%
10,617,463
-2.7%
0.22%
+5.2%
Q2 2017$74,084,000
-36.1%
10,910,760
-11.2%
0.21%
-35.6%
Q1 2017$116,021,000
+9.3%
12,290,330
+0.0%
0.33%
+4.1%
Q4 2016$106,161,000
+33.4%
12,287,200
-2.2%
0.32%
+38.9%
Q3 2016$79,566,000
+43.2%
12,569,690
-4.5%
0.23%
+41.4%
Q2 2016$55,555,000
-5.7%
13,164,690
-2.5%
0.16%
-11.5%
Q1 2016$58,896,000
-28.9%
13,508,2900.0%0.18%
-30.2%
Q4 2015$82,806,000
+7.2%
13,508,2900.0%0.26%
+4.8%
Q3 2015$77,267,000
-23.3%
13,508,2900.0%0.25%
-17.2%
Q2 2015$100,772,000
+24.7%
13,508,2900.0%0.30%
+22.8%
Q1 2015$80,780,000
-20.9%
13,508,2900.0%0.25%
-21.9%
Q4 2014$102,123,000
+45.7%
13,508,2900.0%0.32%
+39.4%
Q3 2014$70,108,000
+20.4%
13,508,2900.0%0.23%
+23.5%
Q2 2014$58,221,000
+5.1%
13,508,290
-0.3%
0.18%
-1.1%
Q1 2014$55,419,000
-17.1%
13,549,790
+8.0%
0.18%
-19.9%
Q4 2013$66,890,000
+6.0%
12,549,7900.0%0.23%
-4.9%
Q3 2013$63,126,000
+12.8%
12,549,7900.0%0.24%
+9.5%
Q2 2013$55,972,000–12,549,790–0.22%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2018.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders